1-6 of 6
Sabine Ponader, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Target Engagement, Pathway Inhibition, and Efficacy Of The Bruton’s Tyrosine Kinase (Btk) Inhibitor CC-292

Daniel W Pierce, Sabine Ponader, PhD, Kumudha Balakrishnan, Varsha Gandhi, PhD, William G. Wierda, MD, Susan O'Brien, MD, Carla Heise, PhD, Mariana Nacht, PhD, Sharon Aslanian, Xiping Liu, Sean Hong, Shijuan Wu, Marianna Zavodovskaya, MS, Jeffrey Marine, Evelyn Barnett, Pilar Nava-Parada, Jay Mei, MD, Rajesh Chopra, MD, Jan A. Burger, MD, PhD, Juswinder Singh
Journal: Blood
Blood (2013) 122 (21): 4169.
https://doi.org/10.1182/blood.V122.21.4169.4169
Published: 2013
Journal Articles

Galectin-1 Serum Levels Reflect Tumor Burden and Adverse Clinical Features in Hodgkin Lymphoma

Jing Ouyang, PhD, Annette Plütschow, PhD, Elke Pogge, PhD, Sabine Ponader, PhD, Gabriel Rabinovich, PhD, Donna S. Neuberg, ScD, Andreas Engert, MD, Margaret A. Shipp, MD
Journal: Blood
Blood (2012) 120 (21): 51.
https://doi.org/10.1182/blood.V120.21.51.51
Published: 2012
Journal Articles

Activity of Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Mantle Cell Lymphoma (MCL) Identifies Btk As a Novel Therapeutic Target,

Sabine Ponader, PhD, Sriram Balasubramanian, PhD, Lan V Pham, PhD, Jun Chen, PhD, Archito T. Tamayo, MS, Michael Wang, MD, Susan O'Brien, MD, William G. Wierda, MD, PhD, Michael J Keating, MD, Richard J. Ford, MD, PhD, Jan A. Burger, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3688.
https://doi.org/10.1182/blood.V118.21.3688.3688
Published: 2011
Journal Articles

Clinical Development of AVL-292; A Potent, Selective Covalent Btk Inhibitor for the Treatment of B Cell Malignancies,

Erica Evans, PhD, Richland Tester, PhD, Sharon Aslanian, Prasoon Chaturvedi, PhD, Hormoz Mazdiyasni, Sabine Ponader, PhD, Bethany Tesar, Michael Sheets, Mariana Nacht, PhD, Kathryn Stiede, Steve Witowski, PhD, Heather Lounsbury, Russell Petter, PhD, Jennifer R. Brown, MD, PhD, Jan A. Burger, MD, PhD, Juswinder Singh, PhD, William F. Westlin, PhD
Journal: Blood
Blood (2011) 118 (21): 3485.
https://doi.org/10.1182/blood.V118.21.3485.3485
Published: 2011
Journal Articles

Microenvironment Influences Expression of TOSO – a Novel NF-Kappa B Target Gene In Chronic Lymphocytic Leukemia

Lukas P. Frenzel, MD, Alexandra Schulz, Christian P. Pallasch, MD, Rainer Claus, MD, Sabine Ponader, PhD, Jan A. Burger, MD, PhD, Michael Hallek, MD, Christoph Plass, PhD, Clemens-Martin Wendtner, MD
Journal: Blood
Blood (2010) 116 (21): 695.
https://doi.org/10.1182/blood.V116.21.695.695
Published: 2010
Journal Articles

Bruton's Tyrosine Kinase Inhibitor PCI-32765 Abrogates BCR- and Nurselike Cell-Derived Activation of CLL Cells In Vitro and In Vivo.

Sabine Ponader, PhD, Joseph Buggy, PhD, Susan O'Brien, BA, MD, William G. Wierda, MD, PhD, Michael Keating, MD, Jan A. Burger, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 45.
https://doi.org/10.1182/blood.V116.21.45.45
Published: 2010